Skip to main content
Skip to footer
We're taking you to another TCS website now.

All pharmaceutical products approved to be used in a market setting have proven benefits but are also associated with adverse effects. The detection of such unknown risks is important to ensure the safety of patients. Signal detection and management in pharmacovigilance necessitates the ongoing monitoring of individual case safety reports (ICSR) to identify case reports of adverse events (AE) that are worthy for further exploration. Traditionally, signals are detected either qualitatively or quantitatively. Qualitative detection involves a deep analysis through manual assessment of the ICSR in an individual or cumulative manner, whereas the quantitative method involves statistical techniques such as disproportionality analysis.
 

In this white paper, we propose a hybrid approach where the algorithm is fuelled to assess a signal and manage it for effective grading based on a qualitative approach.

 

Authors

  • Shubham Chaudhari
    Domain Consultant, TCS ADD Platforms 
  • Achyuth Tanay Kota
    Domain Consultant, TCS ADD Platforms 
  • Ashutosh Pachisia
    Data Scientist, TCS ADD Platforms

Please fill this form to read the whitepaper or click here to read the whitepaper directly.

*Required field
*Enter valid First Name
*Required field
*Enter valid Last Name
*Required field
*Email syntax error
*Please use your business email.
*Required field
*Required field
*Enter valid company name
*Required field

Thank you
for your interest!
Welcome Back
X

Connect with us to transform your workplace

*Required field
*Enter valid First Name
First Name
*Required field
*Enter valid Last Name
Last Name
*Required field
*Email syntax error
*Please use your business email.
Email
*Required field
*Enter valid company name
Company Name
What's your challenge
SEND
Error

Thank you for your interest

We will shortly connect.

Click here to submit another form.